Cargando…

The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients

OBJECTIVES: This study aimed to determine the prevalence and localization of complement factor C4d in renal biopsies from patients with lupus nephritis (LN), as well as its associations with the disease’s clinico-pathological features. The correlation between arteriolar C4d deposition and renal micr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Ying, Yu, Xiaojuan, Wu, Lihua, Tan, Ying, Qu, Zhen, Yu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281350/ https://www.ncbi.nlm.nih.gov/pubmed/34276649 http://dx.doi.org/10.3389/fimmu.2021.654652

Ejemplares similares

Renal microvascular lesions in lupus nephritis
por: Ding, Ying, et al.
Publicado: (2019)

Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
por: Martin, Myriam, et al.
Publicado: (2020)

IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis
por: Ding, Xuewei, et al.
Publicado: (2021)

The spectrum of renal thrombotic microangiopathy in lupus nephritis
por: Song, Di, et al.
Publicado: (2013)

Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis
por: Liu, Xiao-Ling, et al.
Publicado: (2023)

Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis
por: Tan, Ying, et al.
Publicado: (2013)

Role of early repeated renal biopsies in lupus nephritis
por: Zickert, A, et al.
Publicado: (2014)

Do we still need renal biopsy in lupus nephritis?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis
por: Gonzalo-Gil, Elena, et al.
Publicado: (2018)

The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis
por: Hong, Seokchan, et al.
Publicado: (2020)

C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway
por: Wu, Wen-Jun, et al.
Publicado: (2020)

Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity
por: Chen, Dandan, et al.
Publicado: (2022)

Revisiting Vasculopathy in Lupus Nephritis: A Renal Biopsy Evaluation Study
por: Lakshmi, V Ramya, et al.
Publicado: (2022)

4336 Renal Tubular Complement C9 Deposition is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis
por: Wang, Shudan, et al.
Publicado: (2020)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis
por: Wu, Lingling, et al.
Publicado: (2021)

The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice
por: Li, Ying, et al.
Publicado: (2022)

Discovery of NEU1 as a candidate renal biomarker for proliferative lupus nephritis chronicity
por: Mao, Zhaomin, et al.
Publicado: (2021)

Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis
por: Gupta, Krishan L., et al.
Publicado: (2020)

Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China
por: Tan, Meng, et al.
Publicado: (2023)

Serological, fragmentomic, and epigenetic characteristics of cell-free DNA in patients with lupus nephritis
por: Wang, Fang, et al.
Publicado: (2022)

Discovery of Novel Circulating Immune Complexes in Lupus Nephritis Using Immunoproteomics
por: Tang, Chenling, et al.
Publicado: (2022)

Value of repeat biopsy in lupus nephritis flares
por: Greloni, G, et al.
Publicado: (2014)

The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

The significance of electron dense deposits in mild lupus nephritis.
por: Domoto, D. T., et al.
Publicado: (1980)

Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
por: Koopman, Jacob J E, et al.
Publicado: (2020)

The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
por: Moroni, Gabriella, et al.
Publicado: (2015)

Multidisciplinary Lupus Nephritis Clinic Reduces Time to Renal Biopsy and Improves Care Quality
por: Garg, Shivani, et al.
Publicado: (2022)

CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis
por: Olmes, Gregor, et al.
Publicado: (2016)

Lupus nephritis in children – 10 years’ experience
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2016)

Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity
por: Shen, Yiwei, et al.
Publicado: (2023)

Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis
por: Wang, Lin, et al.
Publicado: (2022)

Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
por: Timlin, Homa, et al.
Publicado: (2017)

Clinical relevance of glomerular IgM deposition in patients with lupus nephritis
por: Wang, Fengmei, et al.
Publicado: (2021)

Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus
por: Zhang, Yamei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bv4ioatm8v9dl2cqirno7f1olk